GlassScriptPhysician profile
Atul Matta
NPI 1013398940
$12,172.78
in general payments reported to CMS, 2019-2025
19 companies · $9,608 in 2025
The $9,608 reported for 2025 was more than what 92% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $268 · 2020: $37.70 · 2023: $1,337 · 2024: $923 · 2025: $9,608.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,500 · Travel and Lodging: $2,078 · Food and Beverage: $1,290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,500.00 |
| Travel and Lodging | $2,077.56 |
| Food and Beverage | $1,289.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,627.98 | 2024-2025 | |
| Olympus Corporation of The Americas | $1,092.53 | 2023 | Single Use Suction Valve (Sterile) |
| Glaxosmithkline, LLC. | $391.77 | 2020-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Ethicon INC. | $198.98 | 2025 | Monarch Platform |
| Inspire Medical Systems, INC. | $153.73 | 2025 | Inspire |
| Csl Behring | $122.15 | 2023 | Kcentra |
| Noah Medical Corporation | $117.20 | 2025 | Galaxy |
| Vifor Pharma, INC. | $96.98 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $77.28 | 2023 | Fasenra |
| Janssen Pharmaceuticals, INC | $54.40 | 2019 | |
| Smith+Nephew, INC. | $45.89 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $45.28 | 2019 | |
| Viatris Specialty LLC | $30.72 | 2025 | Yupelri |
| Medtronic, INC. | $27.64 | 2025 | Inceptiv |
| Pfizer INC. | $25.04 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $17.80 | 2025 | Vest Therapy Und |
| Axsome Therapeutics, INC. | $16.49 | 2025 | Sunosi |
| Exact Sciences Corporation | $15.73 | 2025 | Cologuard Collection Kit |
| Gilead Sciences, INC. | $15.19 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Atul Matta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.